CD44 and hepatocellular carcinoma: After IF-based analysis and the characterization of the four newly generated HCC cell lines, we performed cross-validation by gene expression analysis of prominent expressed markers, like HNF4A, ALB, AFP, EGFR, CD44, and CK19, compared to patient-derived isolated cell fractions.